Drug Database
Back to search

Norway· NO-ID_9CB7D21B-299F-4F93-95D6-84E64D323C1B

Omnipaque

A iohexol product containing iohexol, registered in Norway by GE Healthcare AS. The same ATC class is registered in 17 of our 19 countries.

ATC V08AB02

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedOmnipaqueATCV08AB02REGISTER NO.NO-ID_9CB7D21B-299F-4…PACKS LISTED5CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about iohexolAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Iohexol is registered in 17 of 19 countries.

Countries holding a registration under ATC V08AB02 (iohexol), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 9 of them publish a price we can compare per daily dose
Search iohexol products by name

Iohexol · ATC V08AB02

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Iohexol
Manufacturer
GE Healthcare AS
Country
Norway (NO)
ATC code
V08AB02
ATC class
Iohexol
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 5

2 priced
  • no_merkevare_id
    ID_9CB7D21B-299F-4F93-95D6-84E64D323C1B
  • no_varenummer
    582221
    10 x 200
    NOK 4766.8
  • no_varenummer
    019066
    10 x 50
    NOK 1905.3
  • gtin
    7046265822219
  • gtin
    7046260190665

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

353 interactions on record for iohexol.

Graded by severity as the source publishes them — 286 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check iohexol against other medicinesHow interaction checks work

Iohexol · interactions on record

353 records

  • 286 severe
  • 54 moderate
  • 13 info

Most severe, free to view

  • MetoclopramideA03FA01severe
  • ThiethylperazinA04AB03severe
  • TriflupromazinA04AD06severe
  • DronabinolA04AD10severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Iohexol in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All iohexol products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Accupaque, Iovision
  • Belgium · Omnipaque
  • Bulgaria · Kopaq, Контамедиа Йох
  • Cyprus · Omnipaque
  • Czechia · Omnipaque
  • Germany · Accupaque, Iovision
  • Estonia · Iohexol Imax, Omnipaque
  • Spain · Omnipaque
  • Finland · Omnipaque
  • France · Omnipaque
  • United Kingdom (Northern Ireland) · Iohexol Farmak Pharmaceuticals Uk, Iohexol Ge Healthcare
  • Greece · Omnipaque
  • Croatia · Omnipaque
  • Hungary · Iohexol Wogen, Omnipaque
  • Ireland · Omnipaque
  • Iceland · Omnipaque
  • Italy · Omnipaque
  • Lithuania · Iohexol Icg Farma, Iohexol Imax
  • Luxembourg · Omnipaque
  • Latvia · Iohexol Imax, Omnipaque
  • Malta · Omnipaque
  • Netherlands · Iohexol Adoh, Omnipaque
  • Poland · Omnipaque
  • Portugal · Iohexol Imax, Omnipaque
  • Romania · Omnipaque
  • Sweden · Iovision, Omnipaque
  • Slovenia · Omnipaque
  • Slovakia · Omnipaque

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9725de3a-28ff-4126-b983-5f69195df56c
GET /v1/drugs/9725de3a-28ff-4126-b983-5f69195df56c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Injeksjonsvæske, oppløsning",
  "source": "fest",
  "status": "A",
  "atc_name": "Joheksol",
  "merkevare_id": "ID_9CB7D21B-299F-4F93-95D6-84E64D323C1B",
  "name_form_strength": "Omnipaque inj, oppl 140 mg I/ml",
  "prescription_group": "C"
}
API referenceMCP serverPlans

See everything about iohexol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console